MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Xenomics, Inc. (XNOM.PK), a developer of non-invasive, next-generation molecular diagnostics, announces that Dr. Samuil Umansky, Chief Scientific Officer, is scheduled to give a talk today at the “microRNA in Human Disease and Development” conference in Boston, MA. Dr. Umansky will present a new platform technology developed by the company for detection of in vivo cell death by quantitative analysis of miRNA from urine and other bodily fluids.
